Literature DB >> 28042165

Coupled gel spreading and diffusive transport models describing microbicidal drug delivery.

Claire Funke1, Kelsey MacMillan1, Anthony Ham2, Andrew J Szeri1, David F Katz3.   

Abstract

Gels are a drug delivery platform that is being evaluated for application of active pharmaceutical ingredients, termed microbicides, that act topically against vaginal and rectal mucosal infection by sexually transmitted HIV. Despite success in one Phase IIb trial of a vaginal gel delivering tenofovir, problems of user adherence to designed gel application scheduling have compromised results in two other trials. The microbicides field is responding to this dilemma by expanding behavioral analysis of the determinants of adherence while simultaneously improving the pharmacological, biochemical, and biophysical analyses of the determinants of microbicide drug delivery. The intent is to combine results of these two complementary perspectives on microbicide performance and epidemiological success to create an improved product design paradigm. Central to both user sensory perceptions and preferences, key factors that underlie adherence, and to vaginal gel mucosal drug delivery, that underlies anti-HIV efficacy, are gel properties (e.g. rheology) and volume. The specific engineering problem to be solved here is to develop a model for how gel rheology and volume, interacting with loaded drug concentration, govern the transport of the microbicide drug tenofovir into the vaginal mucosa to its stromal layer. These are factors that can be controlled in microbicide gel design. The analysis here builds upon our current understanding of vaginal gel deployment and drug delivery, incorporating key features of the gel's environment, the vaginal canal, fluid production and subsequent gel dilution, and vaginal wall elasticity. These have not previously been included in the modeling of drug delivery. We consider the microbicide drug tenofovir, which is the drug most completely studied for gels: in vitro, in animal studies in vivo, and in human clinical trials with both vaginal or rectal gel application. Our goal is to contribute to improved biophysical and pharmacological understanding of gel functionality, providing a computational tool that can be used in future vaginal microbicide gel design.

Entities:  

Keywords:  Anti-HIV microbicide; Drug delivery; Lubrication flow; Squeezing flow

Year:  2016        PMID: 28042165      PMCID: PMC5193484          DOI: 10.1016/j.ces.2016.05.015

Source DB:  PubMed          Journal:  Chem Eng Sci        ISSN: 0009-2509            Impact factor:   4.311


  21 in total

Review 1.  A vaginal fluid simulant.

Authors:  D H Owen; D F Katz
Journal:  Contraception       Date:  1999-02       Impact factor: 3.375

Review 2.  Microbicides: a new approach to preventing HIV and other sexually transmitted infections.

Authors:  Alan Stone
Journal:  Nat Rev Drug Discov       Date:  2002-12       Impact factor: 84.694

3.  The effects of inhomogeneous boundary dilution on the coating flow of an anti-HIV microbicide vehicle.

Authors:  Savas Tasoglu; Jennifer J Peters; Su Chan Park; Stéphane Verguet; David F Katz; Andrew J Szeri
Journal:  Phys Fluids (1994)       Date:  2011-09-15       Impact factor: 3.521

4.  Design of a semisolid vaginal microbicide gel by relating composition to properties and performance.

Authors:  Alamelu Mahalingam; Eric Smith; Judit Fabian; Festo R Damian; Jennifer J Peters; Meredith R Clark; David R Friend; David F Katz; Patrick F Kiser
Journal:  Pharm Res       Date:  2010-09-15       Impact factor: 4.200

5.  Effectiveness and safety of tenofovir gel, an antiretroviral microbicide, for the prevention of HIV infection in women.

Authors:  Quarraisha Abdool Karim; Salim S Abdool Karim; Janet A Frohlich; Anneke C Grobler; Cheryl Baxter; Leila E Mansoor; Ayesha B M Kharsany; Sengeziwe Sibeko; Koleka P Mlisana; Zaheen Omar; Tanuja N Gengiah; Silvia Maarschalk; Natasha Arulappan; Mukelisiwe Mlotshwa; Lynn Morris; Douglas Taylor
Journal:  Science       Date:  2010-07-19       Impact factor: 47.728

6.  The future of HIV prevention: prospects for an effective anti-HIV microbicide.

Authors:  Jeremy Nuttall; Joseph Romano; Karen Douville; Caroline Galbreath; Annaléne Nel; William Heyward; Mark Mitchnick; Saul Walker; Zeda Rosenberg
Journal:  Infect Dis Clin North Am       Date:  2007-03       Impact factor: 5.982

7.  A model of transluminal flow of an anti-HIV microbicide vehicle: Combined elastic squeezing and gravitational sliding.

Authors:  Andrew J Szeri; Su Chan Park; Stéphane Verguet; Aaron Weiss; David F Katz
Journal:  Phys Fluids (1994)       Date:  2008-08-21       Impact factor: 3.521

8.  Vaginal microbicide gel for delivery of IQP-0528, a pyrimidinedione analog with a dual mechanism of action against HIV-1.

Authors:  Alamelu Mahalingam; Adam P Simmons; Shweta R Ugaonkar; Karen M Watson; Charlene S Dezzutti; Lisa C Rohan; Robert W Buckheit; Patrick F Kiser
Journal:  Antimicrob Agents Chemother       Date:  2011-01-18       Impact factor: 5.191

9.  Transient spreading and swelling behavior of a gel deploying an anti-HIV topical microbicide.

Authors:  Savas Tasoglu; David F Katz; Andrew J Szeri
Journal:  J Nonnewton Fluid Mech       Date:  2012-11       Impact factor: 2.670

Review 10.  Will dapivirine redeem the promises of anti-HIV microbicides? Overview of product design and clinical testing.

Authors:  José das Neves; João Pedro Martins; Bruno Sarmento
Journal:  Adv Drug Deliv Rev       Date:  2015-12-28       Impact factor: 15.470

View more
  2 in total

Review 1.  On-demand microbicide products: design matters.

Authors:  Sravan Kumar Patel; Lisa Cencia Rohan
Journal:  Drug Deliv Transl Res       Date:  2017-12       Impact factor: 4.617

2.  Deducing Mucosal Pharmacokinetics and Pharmacodynamics of the Anti-HIV Molecule Tenofovir from Measurements in Blood.

Authors:  Sachin Govil; David F Katz
Journal:  Sci Rep       Date:  2019-01-14       Impact factor: 4.379

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.